In the cell lab
10 April 2019
A big portion of our in vitro ADME assays are performed using intact cells which have special requirements for assay conditions. To address these requirements these studies are performed in a separate lab dedicated to cell-based work. Why don’t we take a closer look at what goes on in our cell lab?Read more
Metabolites in safety testing (MIST)
5 February 2019
After administration into a body, the drug is usually metabolised into metabolites, which may also be associated with toxic effects. This is why the MIST strategy has evolved to ensure that human metabolites have been adequately covered in the preclinical safety studies. Admescope site manager Sweden Dr Johanna Haglund will describe how to tackle this question.Read more
Looking back to 2018
8 January 2019
Oh dear, too much food and celebrations for the past weeks. Time to throw out the Christmas tree, rip off the seasonal lights, clean the table, and focus our sight firmly forward. However, while waiting to see the sun rise again above the northern snow blanket, it is a good moment to shortly look back to 2018.Read more
Christmas is almost here
18 December 2018
Once again, it’s that time of the year when everybody is rushing to finish their various projects before the year is over. Everyone’s calendar is full and the working pace in the lab and office is at its highest. This can be very stressful time and one should use every opportunity to relax during these hectic weeks.Read more
Biologics vs small molecule drugs – what’s the difference?
19 November 2018
Biologics-based drugs have been increasing their market share over the last decade and the number of companies working with biologics keeps on growing. Last year, 17 new biologics-based drugs were approved by FDA, being the highest yearly approved number of biologics so far. The advances in biotechnology and analytical techniques have facilitated the development in the field, and will most likely continue doing so in the future.Read more